G

GenoFocus Inc
KOSDAQ:187420

Watchlist Manager
GenoFocus Inc
KOSDAQ:187420
Watchlist
Price: 2 850 KRW -1.55%
Market Cap: ₩83B

Net Margin

-8%
Current
Improving
by 20.6%
vs 3-y average of -28.6%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-8%
=
Net Income
₩-3.3B
/
Revenue
₩41B

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-8%
=
Net Income
₩-3.3B
/
Revenue
₩41B

Peer Comparison

Country Company Market Cap Net
Margin
KR
GenoFocus Inc
KOSDAQ:187420
83B KRW
Loading...
US
Sherwin-Williams Co
NYSE:SHW
86.8B USD
Loading...
US
Ecolab Inc
NYSE:ECL
79.7B USD
Loading...
JP
Shin-Etsu Chemical Co Ltd
TSE:4063
9.1T JPY
Loading...
CN
Wanhua Chemical Group Co Ltd
SSE:600309
271.9B CNY
Loading...
CH
Givaudan SA
SIX:GIVN
28.7B CHF
Loading...
DK
Novozymes A/S
CSE:NZYM B
165.6B DKK
Loading...
IN
Asian Paints Ltd
NSE:ASIANPAINT
2.4T INR
Loading...
US
PPG Industries Inc
NYSE:PPG
25.8B USD
Loading...
CH
Sika AG
F:SIKA
19.9B EUR
Loading...
US
Albemarle Corp
NYSE:ALB
21.7B USD
Loading...

Market Distribution

Lower than 77% of companies in Korea
Percentile
23rd
Based on 2 632 companies
23rd percentile
-8%
Low
-168 471.3% — -2.9%
Typical Range
-2.9% — 5.8%
High
5.8% — 21 012.5%
Distribution Statistics
Korea
Min -168 471.3%
30th Percentile -2.9%
Median 1.9%
70th Percentile 5.8%
Max 21 012.5%

GenoFocus Inc
Glance View

Market Cap
83B KRW
Industry
Chemicals

GenoFocus, Inc. engages the research and development of technologies related to biochemical and biotechnology industry. The company is headquartered in Daejeon, Daejeon. The company went IPO on 2015-05-29. The firm mainly manufactures catalases, lactase, phytases and other enzymes. The catalases are mainly used for industry, including processing of semiconductors, petroleum and propylene oxide, medical therapeutics, food processing, contact-lens and other industries. The lactases are mainly used for food processing including processing of milk, yogurt and milk serum. The phytases are mainly used for processing of animal feed. And the Company is exploring new businesses, engaged in development of other enzymes including therapeutic enzymes, chemical agents and others.

GenoFocus Inc Intrinsic Value
HIDDEN
Show
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-8%
=
Net Income
₩-3.3B
/
Revenue
₩41B
What is GenoFocus Inc's current Net Margin?

The current Net Margin for GenoFocus Inc is -8%, which is above its 3-year median of -28.6%.

How has Net Margin changed over time?

Over the last 3 years, GenoFocus Inc’s Net Margin has increased from -32.4% to -8%. During this period, it reached a low of -62.7% on Sep 30, 2023 and a high of 3% on Sep 30, 2024.

Back to Top